Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0883073807309232v1
23/4/421    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Needelman, H.
Right arrow Articles by Bodensteiner, J.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Needelman, H.
Right arrow Articles by Bodensteiner, J.B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Developmental Disabilities
*High Risk Pregnancy
*Premature Babies
Hazardous Substances DB
*DEXAMETHASONE
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effects of Postnatal Dexamethasone Exposure on the Developmental Outcome of Premature Infants

Howard Needelman, MD

Munroe-Meyer Institute for Genetics and Rehabilitation, hneedelm{at}unmc.edu

Martha Evans, MSN, APRN

Children's Hospital of Wisconsin, Milwaukee, Wisconsin

Holly Roberts, PhD

Munroe-Meyer Institute for Genetics and Rehabilitation

Matthew Sweney, MD

Department of Pediatrics University of Nebraska Medical Center, Omaha, Nebraska

J.B. Bodensteiner, MD

Pediatric Neurology, Barrow's Neurologic Institute, St. Joseph Hospital, Phoenix, Arizona

Extremely low birth weight premature infants are at risk for poor neurodevelopmental outcome. Postnatal dexamethasone has often been used in premature infants to prevent or treat bronchopulmonary dysplasia, and this drug is thought by some to affect neurodevelopmental outcome. We retrospectively examined the effect of this steroid on early neurodevelopment. Dexamethasone exposure was associated with an adverse outcome and was a stronger predictor of outcome than other accepted risk factors. If used, dexamethasone should be used in these high-risk infants for as short a period as possible.

Key Words: developmental outcome • dexamethasone • premature infant

This version was published on April 1, 2008

Journal of Child Neurology, Vol. 23, No. 4, 421-424 (2008)
DOI: 10.1177/0883073807309232
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
J. J. Volpe
Cerebellum of the Premature Infant: Rapidly Developing, Vulnerable, Clinically Important
J Child Neurol, September 1, 2009; 24(9): 1085 - 1104.
[Abstract] [PDF]